摘要
目的:观察阿魏酸钠治疗短暂性脑缺血(TIA)发作的疗效及血流变学的变化。方法:将符合标准的入选病例101例分为治疗组和对照组。治疗组52例,给予阿魏酸钠0.2 g,加入250 mL 0.9%氯化钠注射液中静脉滴注;对照组49例,给予丹香冠心注射液20 mL,加入250 mL 0.9%氯化钠注射液中静脉滴注,两组疗程均为14 d,并于治疗结束后随访60 d。结果:2组临床疗效比较,有显著性差异(P<0.05);治疗组较对照组的基本治愈率明显提高(75%vs 50%,P<0.05)。结论:阿魏酸钠治疗TIA疗效确切,可降低脑梗塞的发生率。
OBJECTIVE : To study the clinical effect of ferulate and the hemorheological change in patients with transient ischemic attack (TIA). METHODS: A total of 101 patients coincided with the selecting standard were divided into trial group (n = 52) to be treated with ferulate 0.2g in 0.9 % sodium chloride by iv gtt and control group (n = 49 ) with Danxiangguanxin injection 20ml in 0.9 % sodium chloride by iv gtt. The patients in both groups were followed for 60 days after completion of 14 - day treatment. RESULTS: There was significant difference between the two groups in clinical effects (P 〈 0.05), with the total cure rate in trial group significantly higher than in control group (75% vs. 50%, P 〈 0.05). CONCLUSION: Treatment of TLA with ferulate has proved efficacy and reduced incidence of cerebral infarction.
出处
《中国医院用药评价与分析》
2008年第6期456-457,共2页
Evaluation and Analysis of Drug-use in Hospitals of China
关键词
阿魏酸钠
脑缺血
丹香冠心
Femlate
Cerebral ischemia
Danxiangguanxin